Taiwan FDA registration 59c7990e07e97805026a701f3031a0ac
"Kabi" Fenwal Glycerolyte 57 Solution (non-sterile)
TW: "卡比" 棻沃甘油溶液(未滅菌)
Taiwan·Risk Class 1·MD·BAXTER HEALTHCARE CORPORATION·Registered Jun 12, 2014 – Jun 12, 2024ExpiredRegistration details
- Analysis ID
- 59c7990e07e97805026a701f3031a0ac
- License Form
- Ministry of Health Medical Device Import No. 014240
- Customs Code
- DHA09401424006
Company information
- Manufacturer
- BAXTER HEALTHCARE CORPORATION
- Manufacturer Country
- United States
- Authorized Representative
- FRESENIUS KABI TAIWAN LIMITED
Product details
- Intended Use
- Limited to the first level identification range of cell cryogenic equipment and reactants (B.9225) for in vitro diagnosis of medical device management methods.
- Product Type (Level 1)
- B Hematology and pathology devices
- Product Type (Level 2)
- B9225 Cell cryogenic equipment and reactants for in vitro diagnostics
- Import Information
- Imported from abroad
Dates and status
- Registration Date
- Jun 12, 2014
- Expiry Date
- Jun 12, 2024
About this record
Access comprehensive regulatory information for "Kabi" Fenwal Glycerolyte 57 Solution (non-sterile) in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 1 medical device is registered under number 59c7990e07e97805026a701f3031a0ac and manufactured by BAXTER HEALTHCARE CORPORATION. The authorized representative in Taiwan is FRESENIUS KABI TAIWAN LIMITED.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices